Daiwa Securities Group
DNTH icon

Daiwa Securities Group’s Dianthus Therapeutics DNTH Stock Holding History

Daiwa Securities Group’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed – – 1333
2022
Q3 		$0 Hold
7
– – ﹤0.01% 1354
2022
Q2 		$0 Hold
7
– – ﹤0.01% 1377
2022
Q1 		$0 Hold
7
– – ﹤0.01% 1387
2021
Q4 		$0 Hold
7
– – ﹤0.01% 1403
2021
Q3 		$1K Hold
7
– – ﹤0.01% 1267
2021
Q2 		$1K Hold
7
– – ﹤0.01% 1187
2021
Q1 		$1K Hold
7
– – ﹤0.01% 1193
2020
Q4 		$1K Sell
7
-7
-50% -$794 ﹤0.01% 1172
2020
Q3 		$1K Hold
14
– – ﹤0.01% 1162
2020
Q2 		$1K Hold
14
– – ﹤0.01% 1183
2020
Q1 		$1K Hold
14
– – ﹤0.01% 1186
2019
Q4 		$3K Hold
14
– – ﹤0.01% 1146
2019
Q3 		$2K Hold
14
– – ﹤0.01% 1128
2019
Q2 		$3K Hold
14
– – ﹤0.01% 1128
2019
Q1 		$4K Buy
+14
New +$2.42K ﹤0.01% 1090

Other funds holding DNTH

TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Daiwa Securities Group's DNTH Position: Q4 2022 in Review

Daiwa Securities Group sold out of Dianthus Therapeutics (DNTH) in Q4 2022, closing a stake of 7 shares.

Daiwa Securities Group first reported a position in DNTH in Q1 2019 and held it in 15 quarters. The position peaked at $4K in Q1 2019. 53 funds tracked by Wall St. Rank hold DNTH as of Q4 2022.

  • Daiwa Securities Group reported no remaining Dianthus Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Daiwa Securities Group sold 7 Dianthus Therapeutics shares in Q4 2022.
  • Daiwa Securities Group first reported a position in Dianthus Therapeutics in Q1 2019 and held it in 15 quarters.
  • Daiwa Securities Group's Dianthus Therapeutics position peaked at $4K in Q1 2019.
  • 53 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q4 2022.

Based on Daiwa Securities Group's 13F filing for Q4 2022, filed 6 Feb 2023.